Journal

A practical framework for testing healthcare AI defensibility across evidence, distribution, workflow, trust and professional learning.

Clinical intelligence could become a shared software capability, but source maintenance, permissions and reliable failure handling remain essential.

The clinician's AI desktop may be shaped by record access, permissions and distribution as much as by model quality, with several plausible market outcomes.

The OpenEvidence and Johns Hopkins collaboration raises practical questions about reasoning, assessment and learning when medical evidence is easier to retrieve.

Healthcare AI investment targets different layers of care, but funding, valuation and planned spending must not be confused with realised clinical or financial returns.

NVIDIA's planned minority investment in Doctolib connects AI infrastructure with clinical software, but does not establish clinical superiority or disclose a valuation.

OpenEvidence's $15 billion valuation makes precise usage definitions commercially consequential. The question is how physician activity becomes durable revenue and defensible clini...

Compare Doctolib and OpenEvidence through workflow access, clinical intelligence, business models and the evidence needed before their strategies converge.

Doctolib and OpenEvidence illustrate how clinical AI is converging with records, workflows and education, without making integration a substitute for evidence.

Clinical AI assurance may support durable businesses, but assessment, validation, local deployment and education have different economics and independence constraints.

A practical clinical AI diligence index connects product claims, completed evidence, unresolved risks, dependencies and post-launch responsibilities.

A proposed clinician-facing safety brief makes a clinical AI tool's task, limits, configuration, review requirements and escalation route easier to act on.